Investors can check the status of their share allotment on the BSE or even by logging in to the registrar website.
Firstly, here’s how you can know the status on BSE
Step 1: Visit the BSE Website
Step 2: Please select the issue name, that is the company’s name in the drop down.
Step 3: Enter the application number or PAN number to check the allotment status.
Also Read: Epack Durables IPO: Price band, issue size, GMP among 10 things to know before subscribing to the issue
To check the status of Medi Assist Healthcare allotment through the registrar, which is Link Intime India in this case, kindly follow the below steps.
Step 1: Visit the Link Intime India website
Step 2: Select Medi Assist Healthcare IPO
Step 3: Enter the PAN details and click search to know the status
Medi Assist Healthcare IPO subscription
The public offer of Medi Assist Healthcare was subscribed 16 times at close, led by strong demand from institutional investors, whose category was subscribed 40 times.
Also read: New Swan Multitech sees 90% premium listing over IPO price
Medi Assist Healthcare GMP
According to market analysts, the company’s shares are commanding a premium of Rs 25 in the unlisted market. The IPO was priced at Rs 397-418 apiece.
The company’s shares will likely get listed on the exchanges on January 22 and going by the grey market trends, the stock is expected to debut with 6% premium.
Medi Assist is a health and insurance tech company and manages health benefits for employers, individual members and public systems that primarily serve insurance companies. Founded in 2002, the company acts as an intermediary between insurers, healthcare operators, providing health insurance and cash insurance across more than 14,000 hospitals in India.
The company offers services to 78% of the Nifty 50 companies and 35% of the BSE500 companies.
Medi Assist will not receive any funds from the IPO since it is completely an OFS and the entire proceeds will go to the selling shareholders.
(You can now subscribe to our ETMarkets WhatsApp channel)
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)